Literature DB >> 12638127

Localization of messenger RNAs encoding enzymes associated with malonyl-CoA metabolism in mouse brain.

Annette Sorensen1, Maureen T Travers, Richard G Vernon, Nigel T Price, Michael C Barber.   

Abstract

Malonyl-CoA acts a fuel sensor in the pancreas, liver and muscle. Similarly, malonyl-CoA is implicated in satiety regulation in the brain. Expression of genes encoding enzymes implicated in regulation of malonyl-CoA levels was examined in murine brain. Acetyl-CoA carboxylase (ACC) alpha-isoform, fatty acid synthase and malonyl-CoA decarboxylase are highly expressed in the hippocampus, habenula nucleus, cerebral cortex and areas of the hypothalamus, whereas the ACC-beta isoform and liver-type carnitine palmitoyltransferase I (CPTI-L) are principally expressed in the choroid plexus. Thus different brain regions appear to be functionally configured primarily for either fatty acid synthesis or beta-oxidation. Localization of transcripts encoding enzymes involved in fatty acid synthesis and beta-oxidation in distinct nuclei of the hypothalamus supports a role for malonyl-CoA as a potential effector of satiety.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12638127     DOI: 10.1016/s1567-133x(02)00013-3

Source DB:  PubMed          Journal:  Brain Res Gene Expr Patterns


  3 in total

1.  Beta oxidation in the brain is required for the effects of non-esterified fatty acids on glucose-induced insulin secretion in rats.

Authors:  C Cruciani-Guglielmacci; A Hervalet; L Douared; N M Sanders; B E Levin; A Ktorza; C Magnan
Journal:  Diabetologia       Date:  2004-11-30       Impact factor: 10.122

Review 2.  Sensing the fuels: glucose and lipid signaling in the CNS controlling energy homeostasis.

Authors:  Sabine D Jordan; A Christine Könner; Jens C Brüning
Journal:  Cell Mol Life Sci       Date:  2010-06-12       Impact factor: 9.261

3.  Enteric neuropathy can be induced by high fat diet in vivo and palmitic acid exposure in vitro.

Authors:  Ulrikke Voss; Elin Sand; Björn Olde; Eva Ekblad
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.